• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

  • Published: November 2008
  • Region: Canada
  • 131 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Acumed Medical Ltd.
  • Cordis Corporation
  • Cyberonics, Inc.
  • Elekta AB
  • ev3 Inc.
  • Excel-Tech Ltd.
  • MORE

Canada Neurology Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to Canada neurology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the neurology devices in Canada

Scope

- The report provides neurology devices information broken down into detailed categories and segments in Canada.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- READ MORE >

1 2
1.1 List of Tables 9
1.2 List of Figures 12
2 Introduction 14
2.1 What Is This Report About? 14
3 Definitions of the Markets Covered in the Report 15
3.1 Neurology Devices 15
3.2 CSF (Cerebro Spinal Fluid) Management 15
3.2.1 Hydrocephalus shunt 15
3.2.2 Intra Cranial Pressure (ICP) Monitors 15
3.3 Interventional Neurology 15
3.3.1 Aneurysm Clips 15
3.3.2 Embolic System 15
3.3.3 Navigational System 16
3.4 Neurostimulation Device 16
3.4.1 Spinal Cord Stimulator (SCS) 16
3.4.2 Deep Brain Stimulator (DBS) 16
3.4.3 Vagus Nerve stimulation (VNS) 16
3.5 Neurosurgical Products (Neuroendoscopes) 17
3.5.1 Neuroendoscopes 17
3.6 Radio surgery 17
3.6.1 Cyber Knife Radiosurgery 17
3.6.2 Gamma Knife Radiosurgery 17
4 Healthcare Sector Review 18
4.1 Healthcare Expenditure 18
4.2 Healthcare Infrastructure 20
4.3 Healthcare Policy 24
4.4 Canada Healthcare Trade Statistics 25
5 Regulation System 26
5.1 Medical Equipment Approval Process 26
5.1.1 Classification 26
5.1.2 Conformity Assessment 27
5.1.3 License Fee 29
5.1.4 License Application Processing Duration 29
5.2 Labeling and Packaging 29
5.3 Post-Market Surveillance 30
6 Pricing and Reimbursement 31
7 Distribution Structure 32
7.1 Distribution Structure 32
8 Canada Medical Equipment Cross Market Comparison 33
9 Neurology Devices In Canada 35
9.1 Neurology Devices Cross Country Comparison (2000-2012) 35
9.2 Neurology Devices, Canada, Overall Revenues, 2000-2012 36
9.3 Neurology Devices, Canada, Category Volume, 2000-2012 40
9.4 Neurology Devices, Canada, Company Share (2006-2007) 42
10 CSF Management In Canada 43
10.1 CSF Management Overall Revenue (2000-2012) 43
10.2 CSF Management Overall Volume (2000-2012) 45
10.3 CSF Management Average Price (2000-2012) 47
10.4 CSF Management Distribution Share (2006-2007) 48
10.5 CSF Management, Canada, Company Share (2006-2007) 49
11 Interventional Neurology In Canada 50
11.1 Interventional Neurology Overall Revenue (2000-2012) 50
11.1.1 Embolic Systems Revenue (2000-2012) 52
11.1.2 Navigational Systems Revenue (2000-2012) 54
11.2 Interventional Neurology Overall Volume (2000-2012) 56
11.2.1 Embolic Systems Volume (2000-2012) 58
11.2.2 Navigational Systems Volume (2000-2012) 60
11.3 Interventional Neurology Average Price (2000-2012) 62
11.4 Interventional Neurology Distribution Share (2006-2007) 63
11.5 Interventional Neurology, Canada, Company Share (2006-2007) 64
12 Neurostimulation Devices In Canada 65
12.1 Neurostimulation Devices Overall Revenue (2000-2012) 65
12.2 Neurostimulation Devices Overall Volume (2000-2012) 67
12.3 Neurostimulation Devices Average Price (2000-2012) 69
12.4 Neurostimulation Devices Distribution Share (2006-2007) 70
12.5 Neurostimulation Devices, Canada, Company Share (2006-2007) 71
13 Neurosurgical Products (Neuroendoscopes) In Canada 72
13.1 Neurosurgical Products (Neuroendoscopes) Overall Revenue (2000-2012) 72
13.2 Neurosurgical Products (Neuroendoscopes) Overall Volume (2000-2012) 74
13.3 Neurosurgical Products (Neuroendoscopes) Average Price (2000-2012) 76
13.4 Neurosurgical Products (Neuroendoscopes) Distribution Share (2006-2007) 77
13.5 Neurosurgical Products (Neuroendoscopes), Canada, Company Share (2006-2007) 78
14 Radiosurgery In Canada 79
14.1 Radiosurgery Overall Revenue (2000-2012) 79
14.2 Radiosurgery Overall Volume (2000-2012) 80
14.3 Radiosurgery Average Price (2000-2012) 81
14.4 Radiosurgery Distribution Share (2006-2007) 82
14.5 Radiosurgery, Canada, Company Share (2006-2007) 83
15 Boston Scientific Corporation Company Profile 84
15.1 Company Overview 84
15.2 Value Chain Analysis 84
15.2.1 Manufacturing 84
15.2.2 Product Development 85
15.2.3 Sales and Marketing 86
15.3 Boston Scientific Corporation Pipeline Products 87
15.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type 87
15.3.2 Boston Scientific Corporation Pipeline Products by Development Stage 88
15.3.3 Boston Scientific Corporation Pipeline Products by Therapy Area 89
15.3.4 Boston Scientific Corporation Pipeline Products by Clinical Trials 90
15.3.5 Boston Scientific Corporation Pipeline Products by News Summary 91
16 Elekta AB Company Profile 94
16.1 Company Overview 94
16.2 Value Chain Analysis 94
16.2.1 Manufacturing 94
16.2.2 Product Development 95
16.2.3 Sales and Marketing 95
16.3 Elekta AB Pipeline Products 96
16.3.1 Elekta AB Pipeline Products by Equipment Type 96
16.3.2 Elekta AB Pipeline Products by Development Stage 96
16.3.3 Elekta AB Pipeline Products by Therapy Area 96
16.3.4 Elekta AB Pipeline Products by News Summary 96
17 Medtronic, Inc. Company Profile 97
17.1 Company Overview 97
17.2 Value Chain Analysis 97
17.2.1 Manufacturing 97
17.2.2 Product Development 98
17.2.3 Sales and Marketing 99
17.3 Medtronic, Inc. Pipeline Products 99
17.3.1 Medtronic, Inc. Pipeline Products by Equipment Type 99
17.3.2 Medtronic, Inc. Pipeline Products by Development Stage 101
17.3.3 Medtronic, Inc. Pipeline Products by Therapy Area 103
17.3.4 Medtronic, Inc. Pipeline Products by Clinical Trials 105
17.3.5 Medtronic, Inc. Pipeline Products by News Summary 106
18 ev3 Inc. Company Profile 107
18.1 Company Overview 107
18.2 Value Chain Analysis 107
18.2.1 Manufacturing 107
18.2.2 Product Development 108
18.2.3 Sales and Marketing 108
18.3 ev3 Inc. Pipeline Products 109
18.3.1 ev3 Inc. Pipeline Products by Equipment Type 109
18.3.2 ev3 Inc. Pipeline Products by Development Stage 109
18.3.3 ev3 Inc. Pipeline Products by Therapy Area 110
18.3.4 ev3 Inc. Pipeline Products by Clinical Trials 110
18.3.5 ev3 Inc. Pipeline Products by News Summary 110
19 Cordis Corporation Company Profile 111
19.1 Company Overview 111
19.2 Cordis Corporation Pipeline Products 111
19.2.1 Cordis Corporation Pipeline Products by Equipment Type 111
19.2.2 Cordis Corporation Pipeline Products by Development Stage 111
19.2.3 Cordis Corporation Pipeline Products by Therapy Area 112
19.2.4 Cordis Corporation Pipeline Products by Clinical Trials 112
19.2.5 Cordis Corporation Pipeline Products by News Summary 113
20 Cyberonics, Inc. Company Profile 115
20.1 Company Overview 115
20.2 Cyberonics, Inc. Pipeline Products 115
20.2.1 Cyberonics, Inc. Pipeline Products by Equipment Type 115
20.2.2 Cyberonics, Inc. Pipeline Products by Development Stage 115
20.2.3 Cyberonics, Inc. Pipeline Products by Therapy Area 115
21 Acumed Medical Ltd. Company Profile 116
21.1 Company Overview 116
22 Excel-Tech Ltd. Company Profile 117
22.1 Company Overview 117
23 Medtrode Inc. Company Profile 118
23.1 Company Overview 118
24 Victhom Human Bionics Inc. Company Profile 119
24.1 Company Overview 119
24.2 Victhom Human Bionics Inc. Pipeline Products 119
24.2.1 Victhom Human Bionics Inc. Pipeline Products by Equipment Type 119
24.2.2 Victhom Human Bionics Inc. Pipeline Products by Development Stage 119
24.2.3 Victhom Human Bionics Inc. Pipeline Products by Therapy Area 119
24.2.4 Victhom Human Bionics Inc. Pipeline Products By Clinical Trials 120
24.2.5 Victhom Human Bionics Inc. Pipeline Products By News Summary 120
25 Financial Deals Landscape 121
25.1 Acquisition 121
25.1.1 Natus Medical Acquires Excel-Tech 121
25.2 Partnership 123
25.2.1 Boston Scientific Enters Into Licensing Agreement With Angiotech Pharmaceuticals 123
25.2.2 Innovative Neurotronics Signs An Agreement With BioMotion 124
26 Appendix 126
26.1 Global Markets Direct Research Methodology 126
26.2 Coverage 127
26.3 Secondary Research 127
26.4 Primary Research 128
26.5 Models 128
26.6 Forecasts 129
26.7 Expert Panels 129
26.8 Currency Conversion 130
26.9 Contact Us 131
26.10 Disclaimer 131

Executive Summary

1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004 19
Figure 2: Healthcare Expenditure in Canada, 2000 - 2006 20
Figure 3: Canada, Medical Equipment Market Comparison,2007 33
Figure 4: Neurology Devices Cross Country Comparison (2000-2012) 35
Figure 5: Neurology Devices, Canada, Overall Revenues ($ mn), 2000-2012 36
Figure 6: Neurology Devices, Canada, Portfolio Analysis 37
Figure 7: Neurology Devices, Canada, Overall Revenues ($ mn), Historic, 2000-2007 38
Figure 8: Neurology Devices, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 39
Figure 9: Neurology Devices, Canada, Company Share (%), 2007 42
Figure 10: CSF Management, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 43
Figure 11: CSF Management, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 44
Figure 12: CSF Management, Canada, Overall Volume (Units), Historic, 2000-2007 45
Figure 13: CSF Management, Canada, Overall Volume (Units), Forecast, 2007-2012 46
Figure 14: CSF Management, Canada, Company Share (%), 2007 49
Figure 15: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 50
Figure 16: Interventional Neurology, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 51
Figure 17: Embolic Systems, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 52
Figure 18: Embolic Systems, Canada, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 53
Figure 19: Navigational Systems, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 54
Figure 20: Navigational Systems, Canada, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 55
Figure 21: Interventional Neurology, Canada, Overall Volume (Units), Historic, 2000-2007 56
Figure 22: Interventional Neurology, Canada, Overall Volume (Units), Forecast, 2007-2012 57
Figure 23: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2007 58
Figure 24: Embolic Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2007-2012 59
Figure 25: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Historic, 2000-2007 60
Figure 26: Navigational Systems, Canada, Volume (Units) by Sub-Segment, Forecast, 2007-2012 61
Figure 27: Interventional Neurology, Canada, Company Share (%), 2007 64
Figure 28: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 65
Figure 29: Neurostimulation Devices, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 66
Figure 30: Neurostimulation Devices, Canada, Overall Volume (Units), Historic, 2000-2007 67
Figure 31: Neurostimulation Devices, Canada, Overall Volume (Units), Forecast, 2007-2012 68
Figure 32: Neurostimulation Devices, Canada, Company Share (%), 2007 71
Figure 33: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Historic, 2000-2007 72
Figure 34: Neurosurgical Products (Neuroendoscopes), Canada, Revenue ($ mn), Forecast, 2007-2012 73
Figure 35: Neurosurgical Products (Neuroendoscopes), Canada, Overall Volume (Units), Historic, 2000-2007 74
Figure 36: Neurosurgical Products (Neuroendoscopes), Canada, Overall Volume (Units), Forecast, 2007-2012 75
Figure 37: Neurosurgical Products (Neuroendoscopes), Canada, Company Share (%), 2007 78
Figure 38: Boston Scientific Corporation Value Chain Analysis 84
Figure 39: Elekta AB Value Chain Analysis 94
Figure 40: Medtronic, Inc. Value Chain Analysis 97
Figure 41: ev3 Inc. Value Chain Analysis 107
Figure 42: Global Markets Direct Methodology 126

Boston Scientific Corporation
Elekta AB
Medtronic, Inc.
ev3 Inc.
Cordis Corporation
Cyberonics, Inc.
Acumed Medical Ltd.
Excel-Tech Ltd.
Medtrode Inc.
Victhom Human Bionics Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos